Acquisition of Chemic Laboratories: Solvias Establishes US Laboratory Presence

Expanded Footprint in the US Acquisition of Chemic Laboratories: Solvias Establishes US Laboratory Presence

22.06.2021Editor: MA Alexander Stark

Independent analytical testing, contract research, development and manufacturing company, Solvias, has acquired Massachusetts-based Chemic Laboratories. With this acquisition, the company gains a strong foothold in the United States and highly complementary laboratory testing capabilities.

Related Vendors

Solvias AG

KNF Neuberger GmbH

Solvias, one of the largest independent analytical testing, contract research, development and manufacturing companies.
(Source: Solvias)

Kaiseraugst/Switzerland — Located in the biopharmaceutical hub of Boston, Chemic expands Solvias' global presence and portfolio of integrated testing and analytical services. As one organization, Solvias and Chemic:

support 650+ pharmaceutical corporations, biotech businesses, emerging ATMP companies, as well as medical device and cosmetics companies;

operate nearly 225,000 square feet of laboratory space in Switzerland, France and the United States in accordance with the highest industry standards, including ISO, cGMP and GLP;

offer an extensive suite of analytical services including chemical and physical characterization, quality control, microbiology and cell biology testing and stability testing;

provide combined areas of strengths in synthesis, catalysis and in extractable and leachable testing;

employ more than 600 people possessing deep scientific and technical expertise, with a significant number holding advanced academic degrees.

Chemic is Solvias' first acquisition since partnering with health care investors Water Street Healthcare Partners and JLL Partners in June 2020 to strategically grow the company. Since then, Solvias has recruited industry leaders to join its board and commenced a program to significantly upgrade and expand its information technology platform and infrastructure in support of further global expansion plans. The company is pursuing organic investments and acquisitions to add specialized capabilities to support clients in the growing areas of biologics and cell & gene therapies.

Chemic's co-founders, Messrs. St. Laurent and Goodrich, will join Solvias' leadership team and continue to lead operations in the United States. They also will continue to operate Chemic's product development businesses as separate entities.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

(ID:47477130)